"Its lead product is Thrombosomes, a freeze-dried hemostatic derived from human platelets. Cellphire's technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze